Production & Manufacturing
Production & Manufacturing
Fujifilm to manufacture bulk substance for ThromboGenics’ eye medication
Fujifilm Diosynth Biotechnologies will manufacture the bulk substance for ThromboGenics' FDA approved Jetrea (ocriplasmin) indicated for symptomatic vitreomacular adhesion (VMA). ...
Production & Manufacturing
Mylan Labs to buy SMS Indian manufacturing unit
Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m). ...
Production & Manufacturing
Biostar to manufacture, supply five additional drugs to Xijing...
Biostar Pharmaceuticals has entered into an agreement worth $3m to manufacture and supply five additional drugs to Xijing Hospital for one-year. ...
Production & Manufacturing
Pfizer joins forces with Mylan for generic drugs development
Pfizer and Mylan have entered into a collaboration agreement to develop, manufacture, distribute and market generic drugs in Japan. Under...
Production & Manufacturing
Alexza Adasuve manufacturing facility wins EU Certificate of GMP...
Alexza Pharmaceuticals, a pharmaceutical company, has received EU Certificate of GMP Compliance for its Adasuve manufacturing facility. In May 2012,...
Production & Manufacturing
Tris Pharma completes first phase of manufacturing expansion
Tris Pharma has initiated an expansion of its manufacturing capacity earlier in 2012 and is roughly midway through a 15 month expansion. ...
Production & Manufacturing
Merus Labs acquires Emselex/Enablex drug rights in Canada, Europe
Specialty pharmaceutical company, Merus Labs International, has acquired Emselex/Enablex (darifenacin) extended release tablets rights from Novartis Pharma in Canada and Europe, excluding France, Spain...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.